Awaiting development: Guidance and quality standards
Showing 1 to 1 of 1
| Title | Type |
|---|---|
| Loncastuximab Tesirine + Rituximab for Diffuse large B-cell lymphoma [ID6686] | Technology appraisal guidance |
| Title | Type |
|---|---|
| Loncastuximab Tesirine + Rituximab for Diffuse large B-cell lymphoma [ID6686] | Technology appraisal guidance |